The Janus Henderson B-BBB CLO ETF (JBBB) invests in mid-level collateralized loan obligation (CLO) tranches rated B to BBB, offering a yield around 7%, which is significantly higher than money-market funds. This fund carries credit risk but minimal interest rate risk due to its floating-rate coupons that reset with short-term rates. While it provides higher income, investors should understand the credit risk involved, as these tranches can lose value during economic downturns. JBBB suits yield-seeking investors willing to accept credit risk as part of a diversified portfolio, but it is not a substitute for stable income or principal protection products like T-bills or AAA CLO funds.
Alumis' stock dropped 56.58% after its Phase II lupus drug trial failed to meet main goals, causing a significant market reaction. However, positive results in a subgroup of lupus patients with a high interferon gene signature offer a potential path ...
SPAC stocks like Rising Dragon Acquisition surged nearly 47% amid volatility, while biotech firm bioAffinity Technologies jumped 44% after a reverse stock split. Renewable energy company Fervo Energy gained 28% following a major geothermal power deal...
Alumis Inc. shares dropped 56.76% after its Phase 2b trial for a lupus drug failed to meet key goals, though some patient groups showed promise. Enovis Corporation shares fell 16.51% following its announcement to acquire eCential Robotics for €155 mi...
Vault Strategic Mining Corp has updated the terms of its non-brokered private placement, now offering up to 12 million units at $0.125 each, aiming to raise $1.5 million. Each unit includes one common share and one warrant exercisable at $0.20 within...
Enovis has lowered its price target to $27 from $30 following its binding offer to acquire eCential Robotics for €155 million. This acquisition aims to strengthen Enovis's position in surgical robotics and enhance its ASTRA technology ecosystem. Desp...
